(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 5.33% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.63%.
Albemarle's revenue in 2025 is $4,993,278,000.On average, 10 Wall Street analysts forecast ALB's revenue for 2025 to be $585,482,942,798, with the lowest ALB revenue forecast at $571,586,000,724, and the highest ALB revenue forecast at $627,250,027,560. On average, 10 Wall Street analysts forecast ALB's revenue for 2026 to be $626,705,390,951, with the lowest ALB revenue forecast at $602,065,880,112, and the highest ALB revenue forecast at $683,384,786,124.
In 2027, ALB is forecast to generate $696,160,915,954 in revenue, with the lowest revenue forecast at $679,241,170,088 and the highest revenue forecast at $716,100,641,220.